开发一种利用 LaNiO3 纳米球生产诊断试剂的方法,并将其应用于纳米酶联免疫吸附测定法,以高灵敏度比色法筛查 C 反应蛋白

IF 3.6 3区 化学 Q2 CHEMISTRY, ANALYTICAL
Analyst Pub Date : 2024-10-21 DOI:10.1039/d4an01160k
Maria Nikitina, Pavel Khramtsov, Stepan Devyatov, Rishat G. Valeev, Marina Eremina, Andrey Chukavin, Mikhail Rayev
{"title":"开发一种利用 LaNiO3 纳米球生产诊断试剂的方法,并将其应用于纳米酶联免疫吸附测定法,以高灵敏度比色法筛查 C 反应蛋白","authors":"Maria Nikitina, Pavel Khramtsov, Stepan Devyatov, Rishat G. Valeev, Marina Eremina, Andrey Chukavin, Mikhail Rayev","doi":"10.1039/d4an01160k","DOIUrl":null,"url":null,"abstract":"LaNiO3 perovskite nanoparticles, especially nanospheres (LNNS), show great promise in biomedical assays due to their peroxidase-like catalytic properties. However, LNNS-based diagnostic reagents have not been tested in nanozyme enzyme-linked immunosorbent assay (NLISA) or other enzyme-linked immunosorbent assays, and there is limited data on their synthesis. To fill this gap, it is necessary to develop a method for creating LNNS conjugates with monoclonal antibodies and to investigate the reproducibility, scalability, and applicability of these diagnostic reagents in NLISA. We have successfully developed a method for producing novel diagnostic reagents utilizing LaNiO3 nanospheres. Our research demonstrates the application of these nanospheres in a NLISA specifically designed for the detection of C-reactive protein (CRP) in real serum samples. This method is both reproducible and scalable, allowing for the efficient production of nanospheres that are functionalized with monoclonal antibodies targeting CRP, with mean diameter of approximately 270 nm. Based on the promising results obtained from our experiments, we have developed and optimized a sandwich-format NLISA for CRP detection. This assay achieved lower limit of detection at 0.178 µg/L, with a dynamic range from 12.5 to 0.195 µg/L and a linear detection range extending from 0.195 to 6.25 µg/L, showcasing its potential for clinical applications. The new NLISA method, utilizing LaNiO3 nanospheres in a sandwich format for the detection of CRP, significantly enhances sensitivity compared to similar use horseradish peroxidase-based -ELISA. In this study for the first time first the functionalization of lanthanum nickelate nanospheres with recognition elements have demonstrated. This advancement also sheds light on the technological challenges involved in synthesizing diagnostic reagents, identifying areas that need further exploration.","PeriodicalId":63,"journal":{"name":"Analyst","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The development of a method to produce diagnostic reagents using LaNiO3 nanospheres and their application in nanozyme-linked immunosorbent assay for the colorimetric screening of C-reactive protein with high sensitivity\",\"authors\":\"Maria Nikitina, Pavel Khramtsov, Stepan Devyatov, Rishat G. Valeev, Marina Eremina, Andrey Chukavin, Mikhail Rayev\",\"doi\":\"10.1039/d4an01160k\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"LaNiO3 perovskite nanoparticles, especially nanospheres (LNNS), show great promise in biomedical assays due to their peroxidase-like catalytic properties. However, LNNS-based diagnostic reagents have not been tested in nanozyme enzyme-linked immunosorbent assay (NLISA) or other enzyme-linked immunosorbent assays, and there is limited data on their synthesis. To fill this gap, it is necessary to develop a method for creating LNNS conjugates with monoclonal antibodies and to investigate the reproducibility, scalability, and applicability of these diagnostic reagents in NLISA. We have successfully developed a method for producing novel diagnostic reagents utilizing LaNiO3 nanospheres. Our research demonstrates the application of these nanospheres in a NLISA specifically designed for the detection of C-reactive protein (CRP) in real serum samples. This method is both reproducible and scalable, allowing for the efficient production of nanospheres that are functionalized with monoclonal antibodies targeting CRP, with mean diameter of approximately 270 nm. Based on the promising results obtained from our experiments, we have developed and optimized a sandwich-format NLISA for CRP detection. This assay achieved lower limit of detection at 0.178 µg/L, with a dynamic range from 12.5 to 0.195 µg/L and a linear detection range extending from 0.195 to 6.25 µg/L, showcasing its potential for clinical applications. The new NLISA method, utilizing LaNiO3 nanospheres in a sandwich format for the detection of CRP, significantly enhances sensitivity compared to similar use horseradish peroxidase-based -ELISA. In this study for the first time first the functionalization of lanthanum nickelate nanospheres with recognition elements have demonstrated. This advancement also sheds light on the technological challenges involved in synthesizing diagnostic reagents, identifying areas that need further exploration.\",\"PeriodicalId\":63,\"journal\":{\"name\":\"Analyst\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2024-10-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Analyst\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://doi.org/10.1039/d4an01160k\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analyst","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1039/d4an01160k","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

摘要

由于具有类似过氧化物酶的催化特性,LaNiO3 包晶纳米粒子,尤其是纳米球(LNNS),在生物医学检测中大有可为。然而,基于 LNNS 的诊断试剂尚未在纳米酶联免疫吸附测定(NLISA)或其他酶联免疫吸附测定中进行过测试,有关其合成的数据也很有限。为了填补这一空白,有必要开发一种方法来制造 LNNS 与单克隆抗体的共轭物,并研究这些诊断试剂在 NLISA 中的重现性、可扩展性和适用性。我们已成功开发出一种利用 LaNiO3 纳米球生产新型诊断试剂的方法。我们的研究展示了这些纳米球在 NLISA 中的应用,该 NLISA 专为检测真实血清样本中的 C 反应蛋白 (CRP) 而设计。这种方法具有可重复性和可扩展性,能高效生产出用针对 CRP 的单克隆抗体功能化的纳米球,其平均直径约为 270 nm。基于实验所取得的良好结果,我们开发并优化了一种用于检测 CRP 的夹心式 NLISA 方法。该检测方法的检测下限为 0.178 µg/L,动态范围为 12.5 至 0.195 µg/L,线性检测范围为 0.195 至 6.25 µg/L,展示了其临床应用的潜力。新的 NLISA 方法采用夹心形式的 LaNiO3 纳米球来检测 CRP,与类似的辣根过氧化物酶 -ELISA 相比,灵敏度显著提高。这项研究首次证明了镍酸镧纳米球与识别元素的功能化。这一进展还揭示了合成诊断试剂所面临的技术挑战,确定了需要进一步探索的领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The development of a method to produce diagnostic reagents using LaNiO3 nanospheres and their application in nanozyme-linked immunosorbent assay for the colorimetric screening of C-reactive protein with high sensitivity
LaNiO3 perovskite nanoparticles, especially nanospheres (LNNS), show great promise in biomedical assays due to their peroxidase-like catalytic properties. However, LNNS-based diagnostic reagents have not been tested in nanozyme enzyme-linked immunosorbent assay (NLISA) or other enzyme-linked immunosorbent assays, and there is limited data on their synthesis. To fill this gap, it is necessary to develop a method for creating LNNS conjugates with monoclonal antibodies and to investigate the reproducibility, scalability, and applicability of these diagnostic reagents in NLISA. We have successfully developed a method for producing novel diagnostic reagents utilizing LaNiO3 nanospheres. Our research demonstrates the application of these nanospheres in a NLISA specifically designed for the detection of C-reactive protein (CRP) in real serum samples. This method is both reproducible and scalable, allowing for the efficient production of nanospheres that are functionalized with monoclonal antibodies targeting CRP, with mean diameter of approximately 270 nm. Based on the promising results obtained from our experiments, we have developed and optimized a sandwich-format NLISA for CRP detection. This assay achieved lower limit of detection at 0.178 µg/L, with a dynamic range from 12.5 to 0.195 µg/L and a linear detection range extending from 0.195 to 6.25 µg/L, showcasing its potential for clinical applications. The new NLISA method, utilizing LaNiO3 nanospheres in a sandwich format for the detection of CRP, significantly enhances sensitivity compared to similar use horseradish peroxidase-based -ELISA. In this study for the first time first the functionalization of lanthanum nickelate nanospheres with recognition elements have demonstrated. This advancement also sheds light on the technological challenges involved in synthesizing diagnostic reagents, identifying areas that need further exploration.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Analyst
Analyst 化学-分析化学
CiteScore
7.80
自引率
4.80%
发文量
636
审稿时长
1.9 months
期刊介绍: The home of premier fundamental discoveries, inventions and applications in the analytical and bioanalytical sciences
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信